Family · Pharmaceutical analytical standards
Lercanidipine
A third-generation dihydropyridine calcium channel blocker, created in Italy in the mid-1980s and in use since 1997 for high blood pressure: it widens the arteries by stopping calcium from entering the muscle cells of the vessel walls. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It is so lipophilic that it settles into cell membranes like a reservoir and is released slowly: its effect lasts 24 hours, even though its half-life in the blood is 8-10 hours.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
